IRIS PubliCatt

De Maria Marchiano, Ruggero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.736
EU - Europa 8.556
AS - Asia 4.043
AF - Africa 25
SA - Sud America 22
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 8
Totale 25.404
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.700
PL - Polonia 3.411
CN - Cina 1.994
SE - Svezia 1.828
IT - Italia 931
SG - Singapore 790
IE - Irlanda 642
DE - Germania 420
ID - Indonesia 384
RU - Federazione Russa 275
GB - Regno Unito 260
VN - Vietnam 243
TR - Turchia 242
FR - Francia 196
IN - India 191
UA - Ucraina 163
AT - Austria 145
FI - Finlandia 75
HK - Hong Kong 67
JP - Giappone 43
BE - Belgio 39
CH - Svizzera 29
NL - Olanda 27
IR - Iran 24
ES - Italia 23
CA - Canada 19
RO - Romania 19
BG - Bulgaria 12
BR - Brasile 12
CI - Costa d'Avorio 10
CZ - Repubblica Ceca 10
EU - Europa 10
AU - Australia 8
KR - Corea 8
NO - Norvegia 8
PA - Panama 8
PT - Portogallo 8
SA - Arabia Saudita 8
TW - Taiwan 8
IL - Israele 6
BA - Bosnia-Erzegovina 5
LT - Lituania 5
LU - Lussemburgo 5
PK - Pakistan 5
SC - Seychelles 5
A2 - ???statistics.table.value.countryCode.A2??? 4
PH - Filippine 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
BZ - Belize 3
CO - Colombia 3
GE - Georgia 3
HU - Ungheria 3
IQ - Iraq 3
LK - Sri Lanka 3
MX - Messico 3
CL - Cile 2
CM - Camerun 2
DK - Danimarca 2
EG - Egitto 2
GR - Grecia 2
HR - Croazia 2
KE - Kenya 2
MD - Moldavia 2
MY - Malesia 2
NG - Nigeria 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
AL - Albania 1
BD - Bangladesh 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
JO - Giordania 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
LV - Lettonia 1
MT - Malta 1
MU - Mauritius 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
TT - Trinidad e Tobago 1
ZA - Sudafrica 1
Totale 25.404
Salva come PNG Salva come JPEG
Città #
Warsaw 3.393
Chandler 1.621
Fairfield 1.488
Ashburn 976
Redmond 767
Wilmington 729
Woodbridge 693
Houston 666
Dublin 642
Seattle 633
Singapore 583
Cambridge 507
Nanjing 483
Jakarta 382
Princeton 344
Ann Arbor 335
Hangzhou 310
Boston 288
San Mateo 244
Dong Ket 242
Beijing 210
Dearborn 205
Izmir 202
Jacksonville 200
Cattolica 188
Nanchang 180
Moscow 169
Rome 158
Vienna 143
New York 131
Chicago 122
Milan 108
Shenyang 94
San Diego 84
London 82
Tianjin 76
Bremen 75
Norwalk 74
Hebei 72
Redwood City 69
Kunming 65
Los Angeles 61
Hong Kong 60
Mountain View 60
Jiaxing 52
Marseille 52
Phoenix 44
Brussels 39
Changsha 39
Helsinki 37
Guangzhou 31
Andover 30
Boardman 29
Lawrence 28
Chiswick 27
Augusta 24
Jinan 24
Kocaeli 24
Munich 24
Shanghai 22
Springfield 21
Kish 18
Pune 17
Washington 17
Gloucester 16
Edinburgh 15
Lanzhou 15
Paris 15
Zurich 15
Changchun 14
Fort Worth 14
Hounslow 14
Zhengzhou 14
Forest City 13
Acton 12
Donostia / San Sebastian 11
Falls Church 11
Kraków 11
Abidjan 10
Frankfurt am Main 10
Gunzenhausen 10
Gurgaon 10
Leawood 10
Providence 10
Sofia 10
San Francisco 9
Tokyo 9
Turin 9
Kilburn 8
Lancaster 8
Lappeenranta 8
Santa Clara 8
Stockholm 8
São Paulo 8
Amsterdam 7
Bern 7
Fuzhou 7
Naples 7
Orange 7
Palermo 7
Totale 19.190
Salva come PNG Salva come JPEG
Nome #
CHK1-targeted therapy to deplete DNA replication- stressed, p53-deficient, hyperdiploid colorectal cancer stem cells 359
Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes 311
Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy 301
Protein pathway activation mapping of colorectal metastatic progression reveals metastasis-specific network alterations 300
Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer 296
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer 278
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real- world experience 272
Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer 263
Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer 256
Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer 255
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 254
Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells. 247
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma 246
Two-Step Co-Immunoprecipitation (TIP) Enables Efficient and Highly Selective Isolation of Native Protein-Complexes. 244
Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications 239
A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology 238
Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancer 238
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma 234
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer 234
miR-663 sustains NSCLC by inhibiting mitochondrial outer membrane permeabilization (MOMP) through PUMA/ BBC3 and BTG2 232
Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies 231
GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancer 231
Alliance Against Cancer, the network of Italian cancer centers bridging research and care 230
Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance 230
Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancer 225
miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal 224
Replication stress in colorectal cancer stem cells 224
Expression of phosphorylated Hippo pathway kinases (MST1/2 and LATS1/2) in HER2-positive and triple-negative breast cancer patients treated with neoadjuvant therapy 222
Role of gonadotropin-releasing hormone analogues in metastatic male breast cancer: results from a pooled analysis 221
GLUT 1 receptor expression and circulating levels of fasting glucose in high grade serous ovarian cancer 220
Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes with Different Clinical Outcome 217
(1)H NMR detects different metabolic profiles in glioblastoma stem-like cells 217
Efficacy of chemotherapy in metastatic male breast cancer patients: a retrospective study 215
The Hippo pathway in normal development and cancer 215
Protein drug target activation homogeneity in the face of intra- tumor heterogeneity: implications for precision medicine 212
DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy 206
Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression 206
DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy 205
Analysis of the ATR-Chk1 and ATM- Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression 204
Colorectal cancer: towards new challenges and concepts of preventive healthcare 201
Association between AXL, Hippo Transducers, and Survival Outcomes in Male Breast Cancer 200
HMG-CoAR expression in male breast cancer: Relationship with hormone receptors, Hippo transducers and survival outcomes 189
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 186
Gene Expression Analysis of PTEN Positive Glioblastoma Stem Cells Identifies DUB3 and Wee1 Modulation in a Cell Differentiation Model 182
A BMP7 variant inhibits tumor angiogenesis in vitro and in vivo through direct modulation of endothelial cell biology 165
DNA damage and repair biomarkers in cervical cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis 165
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: A real-world experience 164
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015 161
Antisense RNA for Treating Cancer and Inhibition of Metastasis and Vectors for Antisense Sequestration 149
1H NMR spectroscopy of glioblastoma stem‐like cells identifies alpha‐aminoadipate as a marker of tumor aggressiveness 142
Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go 142
A pre-existing population of ZEB2+ quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer 141
Inhibitor of integrin for the treatment or prevention of tumours 132
Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant 129
“Triple positive” early breast cancer: an observational multicenter retrospective analysis of outcome 118
Alliance Against Cancer, the network of Italian cancer centers bridging research and care 110
Integrin α7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma 108
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 108
C-Met/MIR-130b axis as novel mechanism and biomarker for castration resistance state acquisition 105
C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition 101
HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome 100
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis. 99
C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition 98
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells 97
Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo 96
Integrin a7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma 96
Essential versus accessory aspects of cell death: Recommendations of the NCCD 2015 96
Pluripotency and differentiation in embryos and stem cells 94
CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin 91
Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression 90
Epithelial-mesenchymal transition: a new target in anticancer drug discovery 88
Antitumor effect of miR-197 targeting in p53 wild-type lung cancer 86
Two-Step Co-Immunoprecipitation (TIP) 84
Two-Step Coimmunoprecipitation (TIP) enables efficient and highly selective isolation of native protein complexes 83
The targeting of mre11 or rad51 sensitizes colorectal cancer stem cells to chk1 inhibition 83
Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome 80
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial 80
Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo 79
A real-time integrated framework to support clinical decision making for covid-19 patients 79
BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition 78
Differentiation affects the release of exosomes from colon cancer cells and their ability to modulate the behavior of recipient cells 77
Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer 77
Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells 77
Gene expression analysis of PTEN positive glioblastoma stem cells identifies DUB3 and Wee1 modulation in a cell differentiation model 76
Nobiletin and xanthohumol sensitize colorectal cancer stem cells to standard chemotherapy 76
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 75
A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells 74
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response 73
Blocking the APRIL circuit enhances acute myeloid leukemia cell chemosensitivity 73
1H NMR spectroscopy of glioblastoma stem-like cells identifies alpha-aminoadipate as a marker of tumor aggressiveness 73
Diagnostic and prognostic potential of the proteomic profiling of serum-derived extracellular vesicles in prostate cancer 73
Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo 72
EGFR Inhibition Abrogates Leiomyosarcoma Cell Chemoresistance through Inactivation of Survival Pathways and Impairment of CSC Potential 72
1H NMR detects different metabolic profiles in glioblastoma stem-like cells 71
Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51 71
"Triple positive" early breast cancer: An observational multicenter retrospective analysis of outcome 70
Accreditation for excellence of cancer research institutes: recommendations from the Italian Network of Comprehensive Cancer Centers 67
Protein drug target activation homogeneity in the face of intra-tumor heterogeneity: implications for precision medicine 66
The inhibition of the highly expressed mir-221 and mir-222 impairs the growth of prostate carcinoma xenografts in mice 66
Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer 66
Totale 15.772
Salva come PNG Salva come JPEG
Categoria #
all - tutte 122.859
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.859
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.120 0 0 0 0 312 438 690 319 435 192 567 167
2020/20212.991 257 323 199 149 406 195 477 73 238 217 170 287
2021/20222.787 260 264 126 131 162 145 72 414 132 124 472 485
2022/20235.117 756 695 466 547 372 642 111 447 668 125 200 88
2023/20242.725 101 911 86 132 115 216 200 83 31 84 342 424
2024/20251.330 225 120 482 228 275 0 0 0 0 0 0 0
Totale 25.917